password

username

• Newsletters
• Senders
• Contribute
• Faq

Newsletter preview

Date:

Thu, November 09, 2006 09:11:28 AM

From:

Outsourcing-Pharma

Subject:

09/11 Dowpharma/CRO cost/Charles River/Vetter Pharma/Dendrite

Can't read the email below? Click Here

Today on Outsourcing-Pharma.com   >  Pseudomonas-based protein expression to rival E. coli?   >  Pharma selects CROs on cost and quality criteria   >  Charles River latest CRO to muscle in on Phase I   >  Vetter keeps on expanding lyophilisation services   >  Dendrite wins three year deal

Other top industry news   >  Novartis splashes the cash in Asia   >  Life sciences salaries soar   >  MSD invests €100m in Irish drug making arm   >  Researchers use bacteria to make anti-cancer drugs

	Outsourcing Pharma
Search Forward to a colleague		Thursday 09 November 2006

	Sponsored by Cardinal Health Cardinal Health enhances drug delivery Cardinal Health is a world leader in patented drug-delivery technologies. We develop and manufacture advanced drug-delivery systems and partner with nearly every major global pharmaceutical company. Click Here Access full stories Pseudomonas-based protein expression to rival E. coli? Drug developers are increasingly turning to Pseudomonas-based expression technology for their hard-to-express proteins, according to contract manufacturer Dowpharma... Read Pharma selects CROs on cost and quality criteria According to a new report, CRO's are primarily selected on their scientific expertise and the cost/value ratio... Read Charles River latest CRO to muscle in on Phase I Charles River Laboratories is the latest in a series of large contract research organisations making acquisitions to beef up their Phase I capacity as this market sector remains hot... Read Vetter keeps on expanding lyophilisation services Germany's Vetter Pharma-Fertigung has announced its plan to expand its services by adding vial filling for lyophilised or 'freeze-dried' products to its portfolio... Read Dendrite wins three year deal Dendrite has won a three-year field support services agreement with an undisclosed European pharma firm... Read
	All News Headlines for: November | October | September
	Sponsored by ScinoPharm Taiwan® Experts in small molecule custom synthesis ScinoPharm Taiwan®, Ltd. is a process research, development, and manufacturing service provider of active pharmaceutical ingredients (APIs) to the global pharmaceutical industry. Our expertise is in small molecule custom synthesis. Click Here

Previous Headlines > ClinPhone buys DataLabs to dom ... > Managing clinical risk in East ... > VirtualScopics signs $1.7m ost ... > CROs driving up drug costs, sa ... > Diosynth bags cardiovascular d ... > Aptuit continues service expan ... > Tandem teams up with Qualia ... > Xoma gets EU certification for ... > Ground Zero Pharma expands reg ... > Argos Therapeutics awarded HIV ... Product Categories > Product & Supplier News - Contract Manufacturing Related Web Sites > In-PharmaTechnologist.com > DrugResearcher.com > BioPharmaReporter.com > All our Websites

Other top industry news Novartis splashes the cash in Asia Novartis is splashing its cash in Asia, intending to invest $100m (€79m) in China and INR5bn (€90m) in India to establish large new R&D centres... Read Life sciences salaries soar Salaries in the US life sciences industry have soared this year to reach $74,000 (€58,000) on average as more companies seek to attract and retain top talent by offering competitive remuneration packages, according... Read MSD invests €100m in Irish drug making arm Merck Sharp & Dohme has just announced a €100m investment in South Tipperary, Ireland to build a new formulation R&D centre and drug manufacturing plant... Read Researchers use bacteria to make anti-cancer drugs Scientists are looking into the possibility of using bacteria to make a new library of anti-cancer compounds... Read Events - Publisher's Choice Pharmapack 2007 Two days to turn your packaging projects into reality. Pharmapack 2007 offers the unique opportunity to assist to high profile conferences as well as ... Read STAY up-to-date with pharmaceutical Innovations Visit our regularly updated events calendar and learn about important events within the industry today. ... Read Sponsored by SF-Chem High-quality intermediates SF-Chem is a supplier of high-quality intermediates to customers in the global chemical industry, particularly pharmaceuticals. The company is highly specialised in chlorine and sulfur chemistry. Click Here Forward to a colleague

Subscribe to other Decision News Media e-newsletters - Pharmaceuticals Breaking news Pharmaceutical Technology Drug Discovery Outsourcing Pharma Biopharmaceutical Science and Business Laboratory Equipment Access Decision News Media e-newsletters for the food, beverage & nutition industries click here

	To continue to receive this newsletter in your inbox, please add newsletter@outsourcing-pharma.com to your address book
	Update preferences | Change your email address | ***
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2006 - Decision News Media S.A.S - All Rights Reserved La Tour du Triangle - 26, allee Jules Milhau - 34000 Montpellier - France http://www.decisionnewsmedia.com

 

© 2007 - The Code Kitchen for interface design and text. Newsletter content remains the copyright of the respective publishers.
Contact: info@newsletterarchive.org